We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
401
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $105M | 0.04% |
2,889,911
-63,978
| -2% | -$1.96M |
|
402
EastGroup Properties
EGP
$10.9B
| $104M | 0.04% |
787,571
-92,425
| -11% | -$12.1M |
|
|
SUM
403
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $104M | 0.04% |
4,424,705
+2,992,094
| +209% | +$67.9M |
|
404
Corning
GLW
$143B
| $102M | 0.04% |
3,488,590
+78,742
| +2% | +$2.29M |
|
405
Copart
CPRT
$27.5B
| $101M | 0.04% |
4,456,664
-906,804
| -17% | -$19.4M |
|
406
Enbridge
ENB
$112B
| $101M | 0.04% |
2,537,320
+151,500
| +6% | +$5.66M |
|
407
Regions Financial
RF
$26.8B
| $101M | 0.04% |
5,868,511
-272,258
| -4% | -$4.48M |
|
408
Douglas Emmett
DEI
$1.96B
| $101M | 0.04% |
2,293,837
+436,628
| +24% | +$18.9M |
|
409
Occidental Petroleum
OXY
$55.9B
| $101M | 0.04% |
2,440,183
-1,862,384
| -43% | -$74.6M |
|
410
Omega Healthcare
OHI
$14.7B
| $99.5M | 0.04% |
2,350,522
-228,561
| -9% | -$9.67M |
|
411
Dollar Tree
DLTR
$25.2B
| $99.3M | 0.04% |
1,056,043
-116,395
| -10% | -$12.2M |
|
412
Lumentum
LITE
$69.3B
| $98.9M | 0.04% |
1,246,813
-339,451
| -21% | -$22.2M |
|
413
Lumen
LUMN
$6.44B
| $98.8M | 0.04% |
7,480,404
+324,566
| +5% | +$4.35M |
|
414
Liberty Broadband Class C
LBRDK
$5.15B
| $98.1M | 0.04% |
779,995
-14,431
| -2% | -$1.68M |
|
415
Teleflex
TFX
$5.98B
| $97.9M | 0.04% |
260,042
+88,695
| +52% | +$30.5M |
|
416
Axalta
AXTA
$8.17B
| $97.5M | 0.04% |
3,207,450
-439,422
| -12% | -$13M |
|
417
Emcor
EME
$36B
| $97.3M | 0.04% |
1,126,980
-42,898
| -4% | -$3.78M |
|
418
Arista Networks
ANET
$238B
| $96.8M | 0.04% |
7,611,632
-65,104
| -0.8% | -$856K |
|
419
Starwood Property Trust
STWD
$6.09B
| $96.5M | 0.04% |
3,882,313
-208,026
| -5% | -$5.09M |
|
|
EXAS
420
DELISTED
Exact Sciences
EXAS
| $96.4M | 0.04% |
1,042,801
+52,909
| +5% | +$4.65M |
|
|
HR
421
DELISTED
Healthcare Realty Trust Incorporated
HR
| $96.3M | 0.04% |
2,884,349
+724,030
| +34% | +$24M |
|
422
Cheniere Energy
LNG
$52.9B
| $96.2M | 0.04% |
1,575,548
-330,538
| -17% | -$20.3M |
|
|
QTS
423
DELISTED
QTS REALTY TRUST, INC.
QTS
| $95M | 0.04% |
1,751,030
-150,741
| -8% | -$7.9M |
|
424
McCormick & Company Non-Voting
MKC
$14.2B
| $94.6M | 0.04% |
1,114,826
-4,610
| -0.4% | -$381K |
|
425
Textron
TXT
$15.4B
| $94.6M | 0.04% |
2,120,877
-514,950
| -20% | -$23.9M |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.